Literature DB >> 12378556

A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection.

Takehito Yamamoto1, Makiko Kusama, Kumi Matsuno, Erika Sugiyama, Yasuhiko Yamada, Tatsuji Iga.   

Abstract

Buformin is a widely used as an antidiabetic agent but its renal excretion is still controversial. A new HPLC method with ultraviolet (UV) detection for the determination of buformin in plasma and urine has been developed. After protein precipitation or dilution, buformin and internal standard phenformin were resolved on an octadecyl silica column and detected by UV detection at 233 nm. Intra- and inter-day coefficients of variation were <9%. The limit of quantification was around 0.05 micro g/ml for plasma and 2.5 micro g/ml for urine. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378556     DOI: 10.1002/bmc.182

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Graphene and zeolite as adsorbents in bar-micro-solid phase extraction of pharmaceutical compounds of diverse polarities.

Authors:  Maizatul Najwa Jajuli; Grégoire Herzog; Marc Hébrant; Ng Eng Poh; Afidah Abdul Rahim; Bahruddin Saad; M Hazwan Hussin
Journal:  RSC Adv       Date:  2021-05-04       Impact factor: 4.036

2.  Sensitive determination of buformin using poly-aminobenzoic acid modified glassy carbon electrode.

Authors:  Gui-Ying Jin; Hui Li; Wan-Bang Xu
Journal:  J Pharm Anal       Date:  2012-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.